CHINA PHARMACEUTICALS INC Operating Cash Flow
CHINA PHARMACEUTICALS INC reported Operating Cash Flow of $561.82 thousand for the 6-month period ending 2012-06-30, per its 10-Q/A filed 2012-08-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2012-08-27
- CHINA PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2012-06-30 was $449.69K, a 90.98% decline year-over-year.
- CHINA PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2012-03-31 was $112.14K, a 97.62% decline year-over-year.
- CHINA PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2011-12-31 was $1.98M, a 3007.46% increase year-over-year.
- CHINA PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2011-09-30 was $2.25M.
- CHINA PHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2011 was $13.94M, a 1196.30% increase from fiscal 2010.
- CHINA PHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2010 was $1.08M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2012-06-30 | $449.69K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-27 | $561.82K 10-Q/A · filed 2012-08-27 | $2.55M derived: sum of 3 quarters · filed 2012-08-27 | $4.80M derived: sum of 4 quarters · filed 2012-08-27 |
| 2012-03-31 | $112.14K 10-Q · filed 2012-05-21 | $2.10M derived: sum of 2 quarters · filed 2012-05-21 | $4.35M derived: sum of 3 quarters · filed 2012-05-21 | $9.34M derived: sum of 4 quarters · filed 2012-08-27 |
| 2011-12-31 | $1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-07 | $4.24M derived: sum of 2 quarters · filed 2012-05-07 | $9.22M derived: sum of 3 quarters · filed 2012-08-27 | $13.94M 10-K · filed 2012-05-07 |
| 2011-09-30 | $2.25M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-21 | $7.24M derived: sum of 2 quarters · filed 2012-08-27 | $11.95M 10-Q · filed 2011-11-21 | $12.02M derived: sum of 4 quarters · filed 2012-08-27 |
| 2011-06-30 | $4.99M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-27 | $9.70M 10-Q/A · filed 2012-08-27 | $9.76M derived: sum of 3 quarters · filed 2012-08-27 | $9.25M derived: sum of 4 quarters · filed 2012-08-27 |
| 2011-03-31 | $4.71M 10-Q · filed 2012-05-21 | $4.78M derived: sum of 2 quarters · filed 2012-05-21 | $4.26M derived: sum of 3 quarters · filed 2012-05-21 | |
| 2010-12-31 | $63.86K derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-07 | -$449.59K derived: sum of 2 quarters · filed 2012-05-07 | $1.08M 10-K · filed 2012-05-07 | |
| 2010-09-30 | -$513.45K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-21 | $1.01M 10-Q · filed 2011-11-21 | ||
| 2010-06-30 | $1.52M 10-Q/A · filed 2012-06-20 |